wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38062020-7B302871-1D20-43A8-B7D4-C8A603268DF3
Q38062020-7B302871-1D20-43A8-B7D4-C8A603268DF3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38062020-7B302871-1D20-43A8-B7D4-C8A603268DF3
Treatment options for advanced pancreatic cancer: a review.
P2860
Q38062020-7B302871-1D20-43A8-B7D4-C8A603268DF3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38062020-7B302871-1D20-43A8-B7D4-C8A603268DF3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c839d21a64e60f5d51266c6aef0125bd0650af74
P2860
A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer.